STOCK TITAN

Morgan Stanley discloses 4.15M shares (5.3%) in Vertex (VERX)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Vertex, Inc. institutional ownership report: Morgan Stanley reports beneficial ownership of 4,146,241 shares of Class A Common Stock, representing 5.3% of the class. The filing attributes 4,115,461 shares of shared voting power and 4,146,241 shares of shared dispositive power. The filing is signed by an authorized Morgan Stanley signatory on 05/12/2026.

Positive

  • None.

Negative

  • None.

Insights

Morgan Stanley discloses a ~5.3% economic interest in Vertex Class A shares.

The filing lists 4,146,241 shares as beneficially owned with 5.3% of the class and shows shared voting and dispositive power. This indicates institutional exposure but does not specify trading intent or timing.

Watch subsequent filings for any schedule amendments or Form 13D/4 that would signal active engagement or trades; timing not specified in the excerpt.

The Schedule 13G was executed under passive/institutional reporting conventions.

The filing references the Release No. 34-39538 allocation among MS Reporting Units and is signed by an authorized signatory. It reports shared powers rather than sole control, consistent with aggregated reporting by a financial institution.

Regulatory implications are routine: further disclosure would be required if beneficial ownership or intent changes.

Percent of class 5.3% reported in Schedule 13G
Beneficially owned 4,146,241 shares Class A Common Stock, as reported
Shared voting power 4,115,461 shares reported shared voting power among MS Reporting Units
Sole voting power 0.00 shares reported on the cover responses
Schedule 13G regulatory
"This document is a Schedule 13G filing by Morgan Stanley"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially owned financial
"Amount beneficially owned: See the response(s) to Item 9"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared dispositive power regulatory
"Shared Dispositive Power 4,146,241.00"
MS Reporting Units organizational
"securities beneficially owned by certain operating units (collectively, the "MS Reporting Units")"





92538J106

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Morgan Stanley
Signature:Claire Gordon
Name/Title:Authorized Signatory, Morgan Stanley
Date:05/12/2026

FAQ

What stake does Morgan Stanley report in Vertex (VERX)?

Morgan Stanley reports beneficial ownership of 4,146,241 shares of Vertex Class A common stock, representing 5.3% of the class, as stated in the Schedule 13G filing signed 05/12/2026.

Does Morgan Stanley have voting control over Vertex shares?

The filing shows 4,115,461 shares of shared voting power and 0 shares of sole voting power, indicating voting authority is reported as shared among Morgan Stanley reporting units.

Is this a passive Schedule 13G or an active 13D disclosure for VERX?

This document is a Schedule 13G filing by Morgan Stanley, which is typically used for passive/institutional holders; the filing references the Release No. 34-39538 allocation among MS Reporting Units.

Who signed the Schedule 13G for Morgan Stanley?

The filing is signed by Claire Gordon, as an authorized signatory for Morgan Stanley, with the signature date shown as 05/12/2026 on the cover information.

Does the filing disclose sole dispositive power for Morgan Stanley?

The filing reports 0 shares of sole dispositive power and 4,146,241 shares of shared dispositive power, indicating disposition authority is reported as shared among the MS Reporting Units.